The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EO2401, a novel microbiome-derived therapeutic vaccine for patients with adrenocortical carcinoma (ACC): Preliminary results of the SPENCER study.
 
Eric Baudin
Consulting or Advisory Role - AAA HealthCare; Hutchison MediPharma; Ipsen; Novartis; Pfizer
Research Funding - HRA Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Camilo Jimenez
Honoraria - Merck Sharp & Dohme; Pfizer
Consulting or Advisory Role - HRA Pharma; Lantheus Medical Imaging; Merck Sharp & Dohme; Pfizer; Progenics
Research Funding - Exelixis; Lantheus Medical Imaging; Merck Sharp & Dohme; Progenix
 
Martin Fassnacht
Consulting or Advisory Role - Bayer (Inst); HRA Pharma (Inst)
Research Funding - Corcept Therapeutics (Inst); HRA Pharma (Inst); Ipsen (Inst); Lilly (Inst)
 
Salvatore Grisanti
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb Foundation/Janssen; Sanofi/Aventis
 
Catharina Wilhelmina Menke
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca (Inst); Novartis (Inst); Pfizer (Inst)
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Cristal Therapeutics (Inst); Pfizer (Inst)
 
Harm Haak
No Relationships to Disclose
 
Vivek Subbiah
Consulting or Advisory Role - Helsinn Therapeutics; Loxo; MedImmune; QED Therapeutics; R-Pharm
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Exelixis (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); Inhibrx (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Takeda (Inst); Turning Point Therapeutics (Inst); Vegenics (Inst)
Travel, Accommodations, Expenses - Bayer; Helsinn Therapeutics; Novartis; PharmaMar
Other Relationship - Medscape
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Esteve; Exelixis; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Roche/Genentech; Sanofi
Speakers' Bureau - Bayer; Eisai; Esteve; Hutchison MediPharma; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Ipsen (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Pfizer
 
Christelle De La Fouchardiere
Honoraria - Merck Serono; Merck Serono; Roche; Roche
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; Lilly; MSD Oncology; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Ipsen
Research Funding - Pierre Fabre (Inst); Roche; Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Bristol-Myers Squibb; Celgene; Roche; Roche; Roche; SERVIER
Other Relationship - Incyte; MSD Oncology
 
Dan Granberg
Research Funding - Enterome (Inst); Merck Sharp & Dohme (Inst)
 
Gedske Daugaard
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb/Pfizer; MSD Oncology; Sanofi/Aventis
Travel, Accommodations, Expenses - Astellas Pharma
 
Otilia Kimpel
Honoraria - HRA Pharma
 
Matthias Kroiss
Honoraria - Lilly
Consulting or Advisory Role - Bayer; Eisai; Ipsen; Lilly; Loxo
Research Funding - Enterome; Ipsen; Lilly; Loxo
Travel, Accommodations, Expenses - Lilly
 
Livia Lamartina
Honoraria - Eisai
Consulting or Advisory Role - Bayer; Eisai; Ipsen
Travel, Accommodations, Expenses - Advanced Accelerator Applications
 
Laurent Chêne
Employment - Enterome
Leadership - Enterome
Stock and Other Ownership Interests - Enterome
Patents, Royalties, Other Intellectual Property - Enterome
 
Jean-Michel Paillarse
Employment - Enterome
Stock and Other Ownership Interests - Enterome
Travel, Accommodations, Expenses - Enterome
 
Alfredo Berruti
Consulting or Advisory Role - Amgen; Astellas Pharma; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; Janssen-Cilag
Research Funding - Astellas Pharma (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Sanofi; Sanofi